The United States biopsy devices market size reached US$ 934.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,244.9 Million by 2032, exhibiting a growth rate (CAGR) of 3.14% during 2024-2032.

Biopsy Devices Market - United States

Market Statistics

Market Size in 2023: USD 934.3 Million

Market Forecast in 2032: USD 1,244.9 Million

Market Growth Rate: 3.14% (2024-2032)

The U.S. biopsy devices market is expanding rapidly, driven by advancements in medical technology and increasing demand for minimally invasive procedures. This growth is fueled by the growing focus on early diagnosis and personalized medicine. According to the latest report by IMARC Group, the market is projected to grow at a CAGR of 3.14% from 2024 to 2032.

Download sample copy of the Report: https://www.imarcgroup.com/united-states-biopsy-devices-market/requestsample

United States Biopsy Devices Industry Trends and Drivers:

The United States biopsy devices market is witnessing robust growth driven by several key trends and factors. Below is a bullet-point summary of the main trends and drivers influencing this market.

Key Market Trends

1. Increasing Prevalence of Cancer:

2. The rising incidence of cancer has led to a higher demand for early and accurate diagnostic tools, including biopsy devices.

3. Technological Advancements in Biopsy Techniques:

4. Ongoing advancements in minimally invasive biopsy procedures have improved patient outcomes and reduced recovery times, making these options more attractive to healthcare providers and patients.

5. Growth of Liquid Biopsy:

6. Liquid biopsy, a non-invasive alternative, is gaining traction due to its ability to detect cancer through blood samples, reflecting a shift towards less invasive diagnostic methods.

7. Awareness Campaigns and Screening Programs:

8. The rise in awareness campaigns and screening programs by government and healthcare organizations has boosted the number of biopsies conducted.

9. Integration of AI and Imaging Technologies:

10. The market is benefiting from the integration of artificial intelligence (AI) and imaging technologies, which enhance the precision and efficiency of biopsy procedures.

11. Aging Population:

12. The aging population in the U.S. is contributing to market growth, as older individuals are more likely to require biopsies for various conditions.

Key Market Drivers

1. Demand for Personalized Medicine:

2. The rising demand for personalized medicine, where precise diagnosis through biopsies enables tailored treatment plans, particularly in oncology, is fueling market growth.

3. Increase in Outpatient Biopsy Procedures:

4. The increasing adoption of outpatient biopsy procedures, supported by advancements in portable and easy-to-use biopsy devices, is reducing the need for hospital-based procedures, making biopsies more accessible and cost-effective.

5. Regulatory Support:

6. Regulatory support and fast-tracking of new biopsy technologies by the FDA play a crucial role, encouraging innovation and the quicker introduction of advanced devices into the market.

7. Expansion of Healthcare Infrastructure:

8. The growing healthcare infrastructure, including the expansion of diagnostic centers across the U.S., enhances the availability and frequency of biopsy procedures.

9. Rising Healthcare Expenditure and Insurance Coverage:

10. Increasing healthcare expenditure and enhanced insurance coverage for diagnostic procedures, including biopsies, are making these procedures more affordable for a larger population.

11. Shift Toward Preventive Healthcare and Early Diagnosis:

12. The shift toward preventive healthcare and early diagnosis, driven by consumer demand for better health outcomes, is promoting the uptake of biopsy devices, contributing to the overall market expansion in the U.S.

The United States biopsy devices market is positioned for continued growth, driven by technological advancements, rising cancer prevalence, and an increasing emphasis on personalized medicine and early diagnosis. As these trends and drivers continue to evolve, the market is expected to expand further, offering improved diagnostic capabilities and better patient outcomes.

United States Biopsy Devices Industry Segmentation:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest United States biopsy devices market share. It includes forecasts for the period 2024-2032 and historical data from 2018-2023 for the following segments.

The report has segmented the market into the following categories:

Breakup by Procedure Type:

1. Surgical Biopsy

2. Needle Biopsy

Breakup by Product:

1. Biopsy Guidance Systems

2. Needle Based Biopsy Guns

3. Biopsy Needles

4. Biopsy Forceps

5. Others

Breakup by Application:

1. Breast Biopsy

2. Lung Biopsy

3. Colorectal Biopsy

4. Prostate Biopsy

5. Others

Breakup by Guidance Technique:

1. Ultrasound-guided Biopsy

2. Stereotactic-guided Biopsy

3. MRI-guided Biopsy

4. Others

Breakup by End User:

1. Hospitals and Clinics

2. Academic and Research Institutes

3. Others

Breakup by Region:

1. Northeast

2. Midwest

3. South

4. West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Request for customization:  https://www.imarcgroup.com/request?type=report&id=3212&flag=F

Key highlights of the Report:

1. Market Performance (2018-2023)

2. Market Outlook (2024-2032)

3. COVID-19 Impact on the Market

4. Porter’s Five Forces Analysis

5. Strategic Recommendations

6. Historical, Current and Future Market Trends

7. Market Drivers and Success Factors

8. SWOT Analysis

9. Structure of the Market

10. Value Chain Analysis

11. Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse more research report:

United States Courier Express And Parcel Market Report 2024-2032

United States Security As A Service Market Report 2024-2032

United States Migraine Drugs Market Report 2024-2032

United States Silicon Photonics Market Report 2024-2032

United States Regtech Market Report 2024-2032

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.  IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145